Skip to content
10-Q

Quarterly Report

ACCENTIA BIOPHARMACEUTICALS INC

0001193125-12-354294

← back to feed
Filed
Aug 14, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2012 · Jul 31, 2012 87.69M sh
Shares Diluted Q3 2012 · Jun 30, 2012 120.88M sh
Shares Diluted Q3 2012 · Jun 30, 2012 78.38M sh
Shares Diluted Q3 2012 · Jun 30, 2011 70.17M sh
Shares Diluted Q3 2012 · Jun 30, 2011 67.29M sh
Capex Q3 2012 · Jun 30, 2012 $318.41K
Capex Q3 2012 · Jun 30, 2011 $683.73K
Operating Cash Flow Q3 2012 · Jun 30, 2012 −$4.75M
Operating Cash Flow Q3 2012 · Jun 30, 2011 −$4.46M
Long Term Debt Q3 2012 · Jun 30, 2012 $24.7M
Cash And Equivalents Q3 2012 · Jun 30, 2012 $477.36K
Cash And Equivalents Q3 2012 · Sep 30, 2011 $420.54K
Cash And Equivalents Q3 2012 · Jun 30, 2011 $1.37M
Cash And Equivalents Q3 2012 · Sep 30, 2010 $558.45K
Stockholders Equity Q3 2012 · Jun 30, 2012 −$63.03M
Stockholders Equity Q3 2012 · Sep 30, 2011 −$74.56M
Current Liabilities Q3 2012 · Jun 30, 2012 $51.11M
Current Liabilities Q3 2012 · Sep 30, 2011 $31.27M
Total Liabilities Q3 2012 · Jun 30, 2012 $81.87M
Total Liabilities Q3 2012 · Sep 30, 2011 $92.97M
Current Assets Q3 2012 · Jun 30, 2012 $1.67M
Current Assets Q3 2012 · Sep 30, 2011 $2.87M
Total Assets Q3 2012 · Jun 30, 2012 $3.31M
Total Assets Q3 2012 · Sep 30, 2011 $5.91M
Eps Diluted Q3 2012 · Jun 30, 2012 $0.03
Eps Diluted Q3 2012 · Jun 30, 2012 −$0.02
Eps Diluted Q3 2012 · Jun 30, 2011 −$0.03
Eps Diluted Q3 2012 · Jun 30, 2011 −$0.13
Eps Basic Q3 2012 · Jun 30, 2012 $0.04
Eps Basic Q3 2012 · Jun 30, 2012 −$0.02
Eps Basic Q3 2012 · Jun 30, 2011 −$0.03
Eps Basic Q3 2012 · Jun 30, 2011 −$0.13
Sga Expense Q3 2012 · Jun 30, 2012 $1.18M
Sga Expense Q3 2012 · Jun 30, 2012 $6.13M
Sga Expense restated Q3 2012 · Jun 30, 2011 $3.02M
Sga Expense restated Q3 2012 · Jun 30, 2011 $18.92M
Rd Expense Q3 2012 · Jun 30, 2012 $1.13M
Rd Expense Q3 2012 · Jun 30, 2012 $3.9M
Rd Expense Q3 2012 · Jun 30, 2011 $657.23K
Rd Expense Q3 2012 · Jun 30, 2011 $1.37M
Operating Income Q3 2012 · Jun 30, 2012 −$2.17M
Operating Income Q3 2012 · Jun 30, 2012 −$8.98M
Operating Income restated Q3 2012 · Jun 30, 2011 −$3.27M
Operating Income restated Q3 2012 · Jun 30, 2011 −$19.05M
Gross Profit Q3 2012 · Jun 30, 2012 $174.77K
Gross Profit Q3 2012 · Jun 30, 2012 $1.19M
Gross Profit restated Q3 2012 · Jun 30, 2011 $438.6K
Gross Profit restated Q3 2012 · Jun 30, 2011 $1.36M
Cost Of Revenue Q3 2012 · Jun 30, 2012 $728.39K
Cost Of Revenue Q3 2012 · Jun 30, 2012 $2.16M
Cost Of Revenue restated Q3 2012 · Jun 30, 2011 $628.02K
Cost Of Revenue restated Q3 2012 · Jun 30, 2011 $1.84M
Revenue Q3 2012 · Jun 30, 2012 $903.16K
Revenue Q3 2012 · Jun 30, 2012 $3.35M
Revenue restated Q3 2012 · Jun 30, 2011 $1.07M
Revenue restated Q3 2012 · Jun 30, 2011 $3.2M